BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 21 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $292,068 | +2146.7% | 85,400 | +23426.2% | 0.00% | – |
| Q1 2021 | $13,000 | -87.1% | 363 | -81.7% | 0.00% | – |
| Q4 2020 | $101,000 | +288.5% | 1,981 | +263.5% | 0.00% | – |
| Q3 2020 | $26,000 | -40.9% | 545 | -35.5% | 0.00% | – |
| Q2 2020 | $44,000 | – | 845 | +42150.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 2 | -99.8% | 0.00% | – |
| Q4 2019 | $14,000 | -30.0% | 940 | -65.8% | 0.00% | – |
| Q3 2019 | $20,000 | +5.3% | 2,745 | +60.9% | 0.00% | – |
| Q2 2019 | $19,000 | +58.3% | 1,706 | +39.8% | 0.00% | – |
| Q1 2019 | $12,000 | +140.0% | 1,220 | +0.3% | 0.00% | – |
| Q4 2018 | $5,000 | -44.4% | 1,216 | +1.3% | 0.00% | – |
| Q3 2018 | $9,000 | – | 1,200 | +5614.3% | 0.00% | – |
| Q2 2018 | $0 | – | 21 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LUMINUS MANAGEMENT LLC | 157,099 | $4,565,000 | 0.66% |
| ACT CAPITAL MANAGEMENT, LLC | 42,000 | $1,221,000 | 0.63% |
| Knoll Capital Management, LLC | 20,000 | $581,000 | 0.30% |
| Artemis Investment Management LLP | 1,193,290 | $34,664,000 | 0.30% |
| Ghisallo Capital Management LLC | 225,000 | $6,539,000 | 0.25% |
| Monashee Investment Management LLC | 60,000 | $1,744,000 | 0.21% |
| AlphaCentric Advisors LLC | 25,000 | $727,000 | 0.20% |
| CAAS CAPITAL MANAGEMENT LP | 232,285 | $6,750,000 | 0.11% |
| AllSquare Wealth Management LLC | 5,402 | $157,000 | 0.09% |
| CNA FINANCIAL CORP | 9,479 | $275,000 | 0.08% |